Revelation Biosciences, Inc. (REVBW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-1,436.16 et chiffre d'affaires de $0.00B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-9.44 vs est $-1,436.16 (dépassé +99.3%). 2025: réel $-23.95 vs est $-36.60 (dépassé +34.6%). Précision des analystes: 0%.
